Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Nano-Enabled Drugs: Once Bitten, Twice Shy?

Nanotech-based reformulations of existing drugs have failed to inspire Big Pharma but truly nano-enabled drugs offer real potential for innovation and companies ignore them at their peril.

By Jon Howells and Carys Lloyd at PA Consulting Group (December 2009)

Keywords: Nano-Enabled Drugs, reformulations, Big Pharma, PA COnsulting Group, Howells, Lloyd, Targeted Drug Discovery, Synergistic Collaborations, Metrology

    View full article    |    Back to Delivery systems section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |